John F. Resek joined the firm as a partner in 2017. With over 15 years of experience as a patent attorney, Dr. Resek is a passionate advocate for his clients. The majority of his patent practice focuses on client counseling, opinions of counsel, patent preparation and prosecution, due diligence, and inter-partes proceedings. His clients also benefit from his insights gained as a patent litigator. He frequently advises clients on issues related to the Hatch-Waxman Act.
Dr. Resek has experience with a variety of technologies, but the majority of his work has been with chemistry and the life sciences. He has worked with inventions related to small molecule therapeutics, antibody-based therapeutics, nutraceuticals and chemical engineering. His scientific training was in chemical biology and his technical expertise includes biochemistry, chemistry, medicinal chemistry, molecular biology, pharmacology and protein chemistry.
- J.D., Fordham University School of Law.
- Post-Doctoral with Har Gobind Korhana, Departments of Biology and Chemistry at M.I.T.
- Ph.D., Biochemical Pharmacology University of Wisconsin-Madison.
- B.S., Biochemistry, University of Wisconsin-Madison.
- New York
- New Jersey
- U.S. Patent and Trademark Office
- American Intellectual Property Law Association
- New York Intellectual Property Law Association
Dr. Resek was working as a drug discovery scientist in a biotech company when he decided to exchange his lab coat for a career in patent law. At the time, he had earned a doctorate from the University of Wisconsin, and completed a post-doc at M.I.T. with Nobel Laureate H. Gobind Khorana. Mr. Resek went on to obtain his J.D. from Fordham Law School.
- Resek, JF, COMMENT: Biovail v. Hoechst Aktiengesellschaft, Inc: An Analysis Under the Sherman Act and the Noerr-Pennington Doctrine10 Fordham Intell. Prop. Media & Ent. L.J. 571
- UV crosslinking of adrenergic receptors and ligands. Detection by SDS-PAGE.
- Structure and function in rhodopsin: covalent crosslinking of the rhodopsin (metarhodopsin II)-transducin complex–the rhodopsin cytoplasmic face links to the transducin alpha subunit.
- Formation of the meta II photointermediate is accompanied by conformational changes in the cytoplasmic surface of rhodopsin.
- Photoaffinity labeling the beta-adrenergic receptor with an iodoazido derivative of norepinephrine.
- Resek, J.F. and Korhana, HG A New Photocrosslinking Reagent for Studying Protein-Protein Interaction. The Journal of Organic Chemistry, Vol. 58, pp. 7598-7601, 1993.